189 related articles for article (PubMed ID: 25492048)
1. Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.
Fei F; Guo X; Chen Y; Liu X; Tu J; Xing J; Chen Z; Ji J; He X
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1095-102. PubMed ID: 25492048
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.
Guo X; Chen C; Liu B; Wu Y; Chen Y; Zhou X; Huang X; Li X; Yang H; Chen Z; Xing J
Tumour Biol; 2015 May; 36(5):3931-9. PubMed ID: 25578492
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
[TBL] [Abstract][Full Text] [Related]
4. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in the HIF1A gene modulate response to adjuvant chemotherapy after surgery in patients with colorectal cancer.
Zhang Y; Wang P; Zhou XC; Bao GQ; Lyu ZM; Liu XN; Wan SG; He XL; Huang QC
Asian Pac J Cancer Prev; 2014; 15(11):4637-42. PubMed ID: 24969897
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.
Pinheiro C; Longatto-Filho A; Scapulatempo C; Ferreira L; Martins S; Pellerin L; Rodrigues M; Alves VA; Schmitt F; Baltazar F
Virchows Arch; 2008 Feb; 452(2):139-46. PubMed ID: 18188595
[TBL] [Abstract][Full Text] [Related]
7. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.
Amorim R; Pinheiro C; Miranda-Gonçalves V; Pereira H; Moyer MP; Preto A; Baltazar F
Cancer Lett; 2015 Aug; 365(1):68-78. PubMed ID: 26021766
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
9. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
11. Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy.
Chen J; Su Q; Qin J; Zhou Y; Ruan H; Chen Z; Chen Z; Li H; Zhou Y; Zhou S; Wang X; Zhou L; Huang M
Drug Metab Pharmacokinet; 2019 Jun; 34(3):165-171. PubMed ID: 30952578
[TBL] [Abstract][Full Text] [Related]
12. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
13. Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer.
Dong G; Guo X; Fu X; Wan S; Zhou F; Myers RE; Bao G; Burkart A; Yang H; Xing J
Cancer Sci; 2012 Mar; 103(3):561-8. PubMed ID: 22182247
[TBL] [Abstract][Full Text] [Related]
14. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
15. MCT1 A1470T: a novel polymorphism for sprint performance?
Sawczuk M; Banting LK; Cięszczyk P; Maciejewska-Karłowska A; Zarębska A; Leońska-Duniec A; Jastrzębski Z; Bishop DJ; Eynon N
J Sci Med Sport; 2015 Jan; 18(1):114-8. PubMed ID: 24485392
[TBL] [Abstract][Full Text] [Related]
16. Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.
Eilertsen M; Andersen S; Al-Saad S; Kiselev Y; Donnem T; Stenvold H; Pettersen I; Al-Shibli K; Richardsen E; Busund LT; Bremnes RM
PLoS One; 2014; 9(9):e105038. PubMed ID: 25225794
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
[TBL] [Abstract][Full Text] [Related]
18. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Wu X; Gu J; Wu TT; Swisher SG; Liao Z; Correa AM; Liu J; Etzel CJ; Amos CI; Huang M; Chiang SS; Milas L; Hittelman WN; Ajani JA
J Clin Oncol; 2006 Aug; 24(23):3789-98. PubMed ID: 16785472
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
